Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

ClinicalTrials.gov ID: NCT04757610

Public ClinicalTrials.gov record NCT04757610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 10:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Ranibizumab, Compared With Ranibizumab Alone, in Participants With nAMD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.

Study identification

NCT ID
NCT04757610
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Opthea Limited
Industry
Enrollment
986 participants

Conditions and interventions

Interventions

Biological · Procedure

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 12, 2021 (Actual)
Primary completion
Mar 31, 2025 (Actual)
Completion
Mar 31, 2025 (Actual)
Last update posted
Jul 22, 2025

2021 – 2025

United States locations

U.S. sites
76
U.S. states
24
U.S. cities
70
Facility City State ZIP Site status
ShORe Investigational Site Phoenix Arizona 85016 —
ShORe Investigational Site Phoenix Arizona 85050 —
ShORe Investigational Site Tucson Arizona 85704 —
ShORe Investigational Site Bakersfield California 93309 —
ShORe Investigational Site Campbell California 95008 —
ShORe Investigational Site Encino California 91436 —
ShORe Investigational Site Fullerton California 92835 —
ShORe Investigational Site Glendale California 91203 —
ShORe Investigational Site Huntington Beach California 92647 —
ShORe Investigational Site Laguna Hills California 92653 —
ShORe Investigational Site Long Beach California 90807 —
ShORe Investigational Site Los Angeles California 95817 —
ShORe Investigational Site Mountain View California 94040 —
ShORe Investigational Site Palm Desert California 92211 —
ShORe Investigational site Pasadena California 91107 —
ShORe Investiagtional Site Poway California 92064 —
ShORe Investigational Site Redlands California 92373 —
ShORe Investigational Site Sacramento California 95817 —
ShORe Investigational Site Santa Ana California 92705 —
ShORe Investigational Site Torrance California 90503 —
ShORe Investigational Site Colorado Springs Colorado 80909 —
ShORe Investigational Site Denver Colorado 80206 —
ShORe Investigational Site Lakewood Colorado 80228 —
ShORe Investigational Site Longmont Colorado 80503 —
ShORe Investigational Site Clearwater Florida 33761 —
ShORe Investigational Site Fort Lauderdale Florida 33308 —
ShORe Investigational Site Fort Myers Florida 33912 —
ShORe Investigational Site Gainesville Florida 32607 —
ShORe Investigational Site Lakeland Florida 33805 —
ShORe Investigational Site Pensacola Florida 32503 —
ShORe Investigational Site Pinellas Park Florida 33782 —
ShORe Investigational Site Temple Terrace Florida 33617 —
ShORe Investigational Site Augusta Georgia 30909 —
ShORe Investigational Site Sandy Springs Georgia 30328 —
ShORe Investigational Site Lemont Illinois 60439 —
ShORe Investigational Site Indianapolis Indiana 46290 —
ShORe Investigational Site Baltimore Maryland 21209 —
ShORe Investigational Site Baltimore Maryland 21237 —
ShORe Investigational Site Hagerstown Maryland 21740 —
ShORe Investigational Site Towson Maryland 21204 —
ShORe Investigational Site Springfield Massachusetts 01107 —
ShORe Investigational Site Minneapolis Minnesota 55416 —
ShORe Investigational Site St Louis Missouri 63108 —
ShORe Investigational Site Reno Nevada 89502 —
ShORe Investigational Site Bloomfield New Jersey 07003 —
ShORe Investigational Site Toms River New Jersey 08755 —
ShORe Investigational Site Hauppauge New York 11021 —
ShORe Investigational Site Liverpool New York 13088 —
ShORe Investigational Site Wake Forest North Carolina 27587 —
ShORe Investigational Site Fargo North Dakota 58104 —
ShORe Investigational Site Edmond Oklahoma 73013 —
ShORe Investigational Site Tulsa Oklahoma 74114 —
ShORe Investigational Site Eugene Oregon 97401 —
ShORe Investigational Site Portland Oregon 97225 —
ShORe Investigational Site Portland Oregon 97239 —
ShORe Investigational Site Salem Oregon 97302 —
ShORe Investigational Site Erie Pennsylvania 16507 —
ShORe Investigational Site Beaufort South Carolina 29902 —
ShORe Investigational Site Ladson South Carolina 29456 —
ShORe Investigational Site Nashville Tennessee 37203 —
ShORe Investigational Site Arlington Texas 76012 —
ShORe Investigational Site Austin Texas 78705 —
ShORe Investigational Site Austin Texas 78731 —
ShORe Investigational Site Bellaire Texas 77401 —
ShORe Investigational Site Dallas Texas 75231 —
ShORe Investigational Site Houston Texas 77030 —
ShORe Investigational Site Katy Texas 77494 —
ShORe Investigational Site McAllen Texas 78503 —
ShORe Investigational Site San Antonio Texas 78240 —
ShORe Investigational Site San Antonio Texas 78251 —
ShORe Investigational Site San Antonio Texas 78340 —
ShORe Investigational Site Tyler Texas 75701 —
ShORe Investigational Site Willow Park Texas 76087 —
ShORe Investigational Site Salt Lake City Utah 84107 —
ShORe Investigational Site Charlottesville Virginia 22903 —
ShORe Investigational Site Lynchburg Virginia 24502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04757610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2025 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04757610 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →